(Q34567470)

3 August 2017

title

Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism (English)

1 reference

3 August 2017

Arthur L Burnett

1

1 reference

3 August 2017

Trinity J Bivalacqua

series ordinal

2

1 reference

3 August 2017

Hunter C Champion

series ordinal

3

1 reference

3 August 2017

Biljana Musicki

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

67

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

1043-1048

1 reference

Priapism and impotence in homozygous sickle cell disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

American Urological Association Guideline On The Management of Priapism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Hydroxyurea in the treatment of sickle cell associated priapism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Priapism; Reasons for Failure of Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Experience with 105 patients with priapism: update review of all aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

High-flow priapism associated with Fabry's disease in a child: a case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Priapism: a refined approach to diagnosis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Recurrent prolonged erections and priapism as a sequela of priapism: pathophysiology and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Pathophysiology of priapism: dysregulatory erection physiology thesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Novel nitric oxide signaling mechanisms regulate the erectile response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Allosteric sites of phosphodiesterase-5 sequester cyclic GMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Sildenafil relieves priapism in patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.11.045

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2005.11.045

1 reference

3 August 2017

1 reference